A Metabolic Vulnerability of Vision

Show full item record



Permalink

http://hdl.handle.net/10138/321634

Citation

Tyynismaa , H 2019 , ' A Metabolic Vulnerability of Vision ' , New England Journal of Medicine , vol. 381 , no. 15 , pp. 1474-1476 . https://doi.org/10.1056/NEJMe1910322

Title: A Metabolic Vulnerability of Vision
Author: Tyynismaa, Henna
Contributor: University of Helsinki, STEMM - Stem Cells and Metabolism Research Program
Date: 2019-10-10
Language: eng
Number of pages: 3
Belongs to series: New England Journal of Medicine
ISSN: 0028-4793
URI: http://hdl.handle.net/10138/321634
Abstract: New therapies targeting metabolic vulnerabilities of specific tumor types have created wide interest in recent years. Through research now reported in the Journal by Gantner et al.,(1) metabolic precision therapy may become possible in patients with a rare eye disease, macular telangiectasia type 2, which leads to a progressive loss of central vision in both eyes in middle-aged or older persons.(2) The macula is the small area in the back of the eye that is responsible for high-resolution (i.e., sharp) vision. In the center of the macula is the fovea, which has the highest density of cone photoreceptor cells and . . .
Subject: SERINE PALMITOYLTRANSFERASE
HEREDITARY
MUTATIONS
3121 General medicine, internal medicine and other clinical medicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
nejme1910322.pdf 70.01Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record